Controversies and Opportunities in the Clinical Daily Use of the 21-Gene Assay for Prognostication and Prediction of Chemotherapy Benefit in HR+/HER2- Early Breast Cancer.
Cancers (Basel). 2022 Dec 27;15(1):148. doi: 10.3390/cancers15010148.
Cancers (Basel). 2022.
PMID: 36612144
Free PMC article.
Review.